Searchable abstracts of presentations at key conferences in endocrinology

ea0056p1174 | Thyroid cancer | ECE2018

Correlation of preablative thyroglobulin to the new response to therapy system in differentiated thyroid cancer

Siolos Athanasios , Exadaktylou Paraskevi , Papadopoulos Nikitas , Poimenidou Irini , Rakitzi Pantelitsa , Tziomalos Konstantinos , Chatzipavlidou Vasiliki , Pazaitou-Panayiotou Kalliopi

Introduction: Evidence supports the prognostic value of preablative stimulated thyroglobulin (ps-Tg) for recurrent and persistent disease in patients with differentiated thyroid cancer (DTC). The correlation of ps-Tg with therapeutic response however has been less studied.Objective: To study the correlation of ps-Tg and the trend of serial preablative thyroglobulin measurements(DTg) with the response to treatment restaging system proposed in 2015 America...

ea0081p579 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Association between clinical and genetic factors and glycemic and weight loss response to liraglutide in patients with type 2 diabetes

Kyriakidou Artemis , Kyriazou Angeliki V. , Koufakis Theocharis , Vasilopoulos Yiannis , Grammatiki Maria , Mellidou Eirini , RAKITZI PANTELITSA , Karaliolios Georgios , Goulis Dimitrios , Zebekakis Pantelis , Kotsa Kalliopi

Background: Previous research suggests an association between specific genetic variations and interindividual variability in response to treatment with glucagon-like receptor agonists (GLP-1 RAs) in patients with type 2 diabetes mellitus (T2DM). We aimed to evaluate the role of CTRB1/2 rs7202877 (T>G) polymorphism in glycemic control and weight loss response to liraglutide among Greek patients with T2DM and to identify clinical factors related to prediction of res...